[hlHome]

0

Back to HER2 Breast Cancer Tweetorial: HER2-low emerges as a new classification
HER2 Breast Cancer Tweetorial: HER2-low emerges as a new classification

HER2 Breast Cancer Tweetorial: HER2-low emerges as a new classification

 

This 30-minute, CME/CMLE-accredited, Tweetorial was designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the latest evidence regarding HER2-low breast cancer and HER2 testing guidelines. This Tweetorial will include the following topics: updates from the latest clinical studies on HER2-low breast cancer, HER2-low definition and classification, the clinical implications of HER2-low for the cancer care team, and tools and resources for pathologists.

 

The activity offers 0.5 CME/CMLE credit.

  • List Price: Free
Item Details:

This 30-minute, CME/CMLE-accredited, Tweetorial was designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the latest evidence regarding HER2-low breast cancer and HER2 testing guidelines. This Tweetorial will include the...

Back to HER2 Breast Cancer Tweetorial: HER2-low emerges as a new classification
View More View Less

Bought This Bought That ...